WuXi Biologics’ first GMP campaign in the new MFG3 facility was completed successfully.  The newly completed, 18,000 sq.-ft. clinical manufacturing facility includes process development labs and six production lines: 2 x 2,000L fed-batch, 1 x 1,000L fed-batch and 1 x 200L fed-batch, 1 x 1,000L perfusion and 1 x 500L perfusion. The design can handle production from 50L–2,000L scale fed-batch production and 125L–1,000L scale perfusion production. The facility offers traditional fed-...